Switch to
More onapp

How to use scorecard? Learn more

Marksans Pharma Ltd

MARKSANS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,717 cr, stock is ranked 619
High RiskStock is 3.48x as volatile as Nifty
104.700.60 (+0.58%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,717 cr, stock is ranked 619
High RiskStock is 3.48x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
17.14
PB RatioPB Ratio
2.67
Dividend YieldDiv. Yield
0.48%
Sector PESector PE
40.05
Sector PBSector PB
4.70
Sector Div YldSctr Div Yld
0.78%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Marksans Pharma Limited is a pharmaceutical company, which is engaged in the research, manufacturing and marketing of generic pharmaceutical formulations.

Investor PresentationView older 

Aug 11, 2023

PDF
View Older Presentations

Financial TrendFinancial statements 

20202021202220231.131.381.531.910.120.240.180.27
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 5.15%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 1.93%

See detailed holdings

Recent EventsAll events 

Loss of Share Certificates 
Announced OnAug 31, 2023

Marksans Pharma Limited has informed the Exchange about Loss of Share Certificates | Download

Marksans Pharma Limited has informed the Exchange about Loss of Share Certificates | Download

Amendment to AOA/MOA 
Announced OnAug 30, 2023

Marksans Pharma Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company. | Download

Marksans Pharma Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company. | Download

Cash Dividend 
Ex. DateJun 7, 2023

Final • Div/Share: ₹ 0.5

See all events